These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 32982951)
21. Age over 80 years is not associated with increased hemorrhagic transformation after stroke thrombolysis. Costello CA; Campbell BC; Perez de la Ossa N; Zheng TH; Sherwin JC; Weir L; Hand P; Yan B; Desmond PM; Davis SM J Clin Neurosci; 2012 Mar; 19(3):360-3. PubMed ID: 22245278 [TBL] [Abstract][Full Text] [Related]
22. Hemorrhagic Transformation in Acute Ischemic Stroke: A Quantitative Systematic Review. Honig A; Percy J; Sepehry AA; Gomez AG; Field TS; Benavente OR J Clin Med; 2022 Feb; 11(5):. PubMed ID: 35268253 [TBL] [Abstract][Full Text] [Related]
23. Postthrombolysis blood pressure elevation is associated with hemorrhagic transformation. Butcher K; Christensen S; Parsons M; De Silva DA; Ebinger M; Levi C; Jeerakathil T; Campbell BC; Barber PA; Bladin C; Fink J; Tress B; Donnan GA; Davis SM; Stroke; 2010 Jan; 41(1):72-7. PubMed ID: 19926841 [TBL] [Abstract][Full Text] [Related]
24. [Factors related to therapeutic outcomes of intravenous thrombolysis in stroke patients with different severity]. Yan XB; Zhang S; Lou M Zhejiang Da Xue Xue Bao Yi Xue Ban; 2015 Jan; 44(1):54-60. PubMed ID: 25851976 [TBL] [Abstract][Full Text] [Related]
25. Early hemorrhagic transformation of brain infarction: rate, predictive factors, and influence on clinical outcome: results of a prospective multicenter study. Paciaroni M; Agnelli G; Corea F; Ageno W; Alberti A; Lanari A; Caso V; Micheli S; Bertolani L; Venti M; Palmerini F; Biagini S; Comi G; Previdi P; Silvestrelli G Stroke; 2008 Aug; 39(8):2249-56. PubMed ID: 18535273 [TBL] [Abstract][Full Text] [Related]
26. [Effects of simultaneous use of Cerebrolysin and alteplase on hemorrhagic transformation of brain infarction and functional outcome in stroke patients: CEREHETIS, a randomized, multicenter pilot trial]. Khasanova DR; Kalinin MN Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(8. Vyp. 2):60-69. PubMed ID: 37682097 [TBL] [Abstract][Full Text] [Related]
28. Quantitative Signal Intensity in Fluid-Attenuated Inversion Recovery and Treatment Effect in the WAKE-UP Trial. Cheng B; Boutitie F; Nickel A; Wouters A; Cho TH; Ebinger M; Endres M; Fiebach JB; Fiehler J; Galinovic I; Puig J; Thijs V; Lemmens R; Muir KW; Nighoghossian N; Pedraza S; Simonsen CZ; Gerloff C; Thomalla G; Stroke; 2020 Jan; 51(1):209-215. PubMed ID: 31662118 [TBL] [Abstract][Full Text] [Related]
29. Effect of Alteplase vs Aspirin on Functional Outcome for Patients With Acute Ischemic Stroke and Minor Nondisabling Neurologic Deficits: The PRISMS Randomized Clinical Trial. Khatri P; Kleindorfer DO; Devlin T; Sawyer RN; Starr M; Mejilla J; Broderick J; Chatterjee A; Jauch EC; Levine SR; Romano JG; Saver JL; Vagal A; Purdon B; Devenport J; Pavlov A; Yeatts SD; JAMA; 2018 Jul; 320(2):156-166. PubMed ID: 29998337 [TBL] [Abstract][Full Text] [Related]
30. Thrombolysis With Alteplase at 0.6 mg/kg for Stroke With Unknown Time of Onset: A Randomized Controlled Trial. Koga M; Yamamoto H; Inoue M; Asakura K; Aoki J; Hamasaki T; Kanzawa T; Kondo R; Ohtaki M; Itabashi R; Kamiyama K; Iwama T; Nakase T; Yakushiji Y; Igarashi S; Nagakane Y; Takizawa S; Okada Y; Doijiri R; Tsujino A; Ito Y; Ohnishi H; Inoue T; Takagi Y; Hasegawa Y; Shiokawa Y; Sakai N; Osaki M; Uesaka Y; Yoshimura S; Urabe T; Ueda T; Ihara M; Kitazono T; Sasaki M; Oita A; Yoshimura S; Fukuda-Doi M; Miwa K; Kimura K; Minematsu K; Toyoda K; Stroke; 2020 May; 51(5):1530-1538. PubMed ID: 32248771 [TBL] [Abstract][Full Text] [Related]
31. Risk factors and functional outcome were associated with hemorrhagic transformation after mechanical thrombectomy for acute large vessel occlusion stroke. Li W; Xing X; Wen C; Liu H J Neurosurg Sci; 2023 Oct; 67(5):585-590. PubMed ID: 33320467 [TBL] [Abstract][Full Text] [Related]
32. Effectiveness and Predictors of Poor Prognosis Following Intravenous Thrombolysis in Patients with Wake-Up Ischemic Stroke Guided by Rapid MRI. Lu Q; Bai Q; Ren H; Zhu B; Jiang T; Peng C; Chen X Neuropsychiatr Dis Treat; 2022; 18():317-325. PubMed ID: 35210778 [TBL] [Abstract][Full Text] [Related]
33. A multicenter, randomized, double-blind, placebo-controlled trial to test efficacy and safety of magnetic resonance imaging-based thrombolysis in wake-up stroke (WAKE-UP). Thomalla G; Fiebach JB; Østergaard L; Pedraza S; Thijs V; Nighoghossian N; Roy P; Muir KW; Ebinger M; Cheng B; Galinovic I; Cho TH; Puig J; Boutitie F; Simonsen CZ; Endres M; Fiehler J; Gerloff C; Int J Stroke; 2014 Aug; 9(6):829-36. PubMed ID: 23490032 [TBL] [Abstract][Full Text] [Related]
34. Perfusion computed tomography-guided intravenous thrombolysis for acute ischemic stroke beyond 4.5 hours: a case-control study. García-Bermejo P; Calleja AI; Pérez-Fernández S; Cortijo E; del Monte JM; García-Porrero M; Fe Muñoz M; Fernández-Herranz R; Arenillas JF Cerebrovasc Dis; 2012; 34(1):31-7. PubMed ID: 22759450 [TBL] [Abstract][Full Text] [Related]
35. Impact of leukoaraiosis on parenchymal hemorrhage in elderly patients treated with thrombolysis. Nighoghossian N; Abbas F; Cho TH; Geraldo AF; Cottaz V; Janecek E; Mechtouff L; Bischoff M; El Khoury C; Schott AM; Derex L; Hermier M; Tisserand LG; Amelie R; Chamard L; Berthezene Y Neuroradiology; 2016 Oct; 58(10):961-967. PubMed ID: 27447872 [TBL] [Abstract][Full Text] [Related]
36. Serious Adverse Events and Their Impact on Functional Outcome in Acute Ischemic Stroke in the WAKE-UP Trial. Lettow I; Jensen M; Schlemm E; Boutitie F; Quandt F; Cheng B; Ebinger M; Endres M; Fiebach JB; Thijs V; Lemmens R; Muir KW; Nighoghossian N; Pedraza S; Simonsen CZ; Gerloff C; Thomalla G; Stroke; 2021 Dec; 52(12):3768-3776. PubMed ID: 34433305 [TBL] [Abstract][Full Text] [Related]
37. Predictors of hemorrhagic transformation after intravenous recombinant tissue plasminogen activator: prognostic value of the initial apparent diffusion coefficient and diffusion-weighted lesion volume. Selim M; Fink JN; Kumar S; Caplan LR; Horkan C; Chen Y; Linfante I; Schlaug G Stroke; 2002 Aug; 33(8):2047-52. PubMed ID: 12154261 [TBL] [Abstract][Full Text] [Related]
38. Low- Versus Standard-Dose Alteplase in Patients on Prior Antiplatelet Therapy: The ENCHANTED Trial (Enhanced Control of Hypertension and Thrombolysis Stroke Study). Robinson TG; Wang X; Arima H; Bath PM; Billot L; Broderick JP; Demchuk AM; Donnan GA; Kim JS; Lavados PM; Lee TH; Lindley RI; Martins SCO; Olavarria VV; Pandian JD; Parsons MW; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Nguyen TH; Wang JG; Woodward M; Chalmers J; Anderson CS; Stroke; 2017 Jul; 48(7):1877-1883. PubMed ID: 28619989 [TBL] [Abstract][Full Text] [Related]
39. Clinical implication of hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator. Ho BL; Chen CF; Lin RT; Liu CK; Chao AC Neurol Sci; 2016 Nov; 37(11):1799-1805. PubMed ID: 27423451 [TBL] [Abstract][Full Text] [Related]
40. Systolic Blood Pressure Variability is Associated with Severe Hemorrhagic Transformation in the Early Stage After Thrombolysis. Liu K; Yan S; Zhang S; Guo Y; Lou M Transl Stroke Res; 2016 Jun; 7(3):186-91. PubMed ID: 26892891 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]